Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Burke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Neurosciences in Rural Practice|April 3, 2013
CommentaryRachel A Burke
Journal of Central Nervous System Disease|May 8, 2013
Review of the treatment of restless legs syndrome: focus on gabapentin enacarbilRachel A Burke, Michele A Faulkner
Expert Opinion on Pharmacotherapy|November 15, 2011
Gabapentin enacarbil for the treatment of restless legs syndrome (RLS)Rachel A Burke, Michele A Faulkner
Expert Opinion on Drug Safety|July 26, 2013
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanelMichele A Faulkner, Rachel A Burke
American Journal of Surgery|October 10, 2025
Pancreaticojejunostomy with duct-to-mucosa versus invagination techniques: a propensity-score matching analysis based on pancreatic duct size and gland textureApostolos Gaitanidis, Winifred M Lo, Rachel A Burke, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Neurosciences in Rural Practice|April 3, 2013
CommentaryRachel A Burke
Journal of Central Nervous System Disease|May 8, 2013
Review of the treatment of restless legs syndrome: focus on gabapentin enacarbilRachel A Burke, Michele A Faulkner
Expert Opinion on Pharmacotherapy|November 15, 2011
Gabapentin enacarbil for the treatment of restless legs syndrome (RLS)Rachel A Burke, Michele A Faulkner
Expert Opinion on Drug Safety|July 26, 2013
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanelMichele A Faulkner, Rachel A Burke
American Journal of Surgery|October 10, 2025
Pancreaticojejunostomy with duct-to-mucosa versus invagination techniques: a propensity-score matching analysis based on pancreatic duct size and gland textureApostolos Gaitanidis, Winifred M Lo, Rachel A Burke, et al.
Pageof 1